Placenta growth factor mediated gene regulation in sickle cell disease. Issue 1 (January 2018)

• Record Type: Journal Article
• Authors: Kalra, Vijay K.; Zhang, Shuxiao; Malik, Punam; Tahara, Stanley M.
• Is Part Of: Blood reviews. Volume 32:Issue 1(2018:Jan.)
• Page Start: 61
• Page End: 70
• Publication Date: 2018-01
• Subjects: Sickle cell anemia -- Pulmonary hypertension -- Placenta growth factor -- Hypoxia-inducible factor -- microRNAs -- Transcriptional and post-transcriptional regulation; Hematology -- Periodicals; Hematology -- Periodicals; Hématologie -- Périodiques; Hematology; Electronic journals; Periodicals; 616.15
• DOI: 10.1016/j.blre.2017.08.008
• Languages: English
• ISSNs: 0268-960X

Abstract

Abstract: Sickle cell anemia (SCA) is an autosomal recessive disorder caused by mutation in the β-globin gene. Pulmonary hypertension (PH), a complication of SCA, results in severe morbidity and mortality. PH is a multifactorial disease: systemic vasculopathy, pulmonary vasoconstriction, and endothelial dysfunction and remodeling. Placenta growth factor (PlGF), an angiogenic growth factor, elaborated from erythroid cells, has been shown to contribute to inflammation, pulmonary vasoconstriction and airway hyper-responsiveness (AH) in mouse models of sickle cell disease. In this review, we summarize the cell-signaling mechanism(s) by which PlGF regulates the expression of genes involved in inflammation, PH and AH in cell culture and corroborate these findings in mouse models of SCA and in individuals with SCA. The role of microRNAs (miRNAs) in the post-transcriptional regulation of these genes is presented and how these miRNAs located in their host genes are transcriptionally regulated. An understanding of the transcriptional regulation of these miRNAs provides a new therapeutic approach to ameliorate the clinical manifestations of SCA.